A detailed history of Bank Of New Hampshire transactions in Zoetis Inc. stock. As of the latest transaction made, Bank Of New Hampshire holds 197 shares of ZTS stock, worth $34,593. This represents 0.01% of its overall portfolio holdings.

Number of Shares
197
Previous 204 3.43%
Holding current value
$34,593
Previous $34,000 -0.0%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 01, 2024

SELL
$145.54 - $178.83 $1,018 - $1,251
-7 Reduced 3.43%
197 $34,000
Q3 2023

Oct 10, 2023

SELL
$167.14 - $192.77 $34,430 - $39,710
-206 Reduced 50.24%
204 $35,000
Q2 2023

Jul 28, 2023

BUY
$160.94 - $186.23 $1,126 - $1,303
7 Added 1.74%
410 $70,000
Q4 2022

Jan 10, 2023

SELL
$131.14 - $157.47 $7,868 - $9,448
-60 Reduced 12.96%
403 $59,000
Q1 2022

Apr 20, 2022

BUY
$181.39 - $234.03 $83,983 - $108,355
463 New
463 $87,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.2B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Bank Of New Hampshire Portfolio

Follow Bank Of New Hampshire and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New Hampshire, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New Hampshire with notifications on news.